GlassScriptPhysician profile
Derek Omori
NPI 1699143263
$714.87
in general payments reported to CMS, 2019-2025
10 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.90 · 2022: $25.83 · 2023: $131 · 2024: $301 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $327.86 | 2024-2025 | Zipseal 24 Surgical Skin Closure Kit, Mako, Insignia |
| Zimmer Biomet Holdings, INC. | $94.30 | 2022-2025 | Persona |
| Solventum Corporation | $73.55 | 2024 | Prevena Restor Axioform, V.A.C.Ulta, Ioban 2 |
| Medical Device Business Services, INC. | $65.00 | 2023 | Stratafix |
| Heron Therapeutics, INC. | $43.90 | 2021 | |
| Orthofix Medical, INC. | $31.61 | 2023-2025 | Physio-Stim |
| Boston Scientific Corporation | $24.88 | 2024 | Wavewriter Alpha Prime 16 |
| Vericel Corporation | $20.70 | 2023 | Maci |
| Innovation Technologies INC | $18.06 | 2023 | Irrisept |
| Ferring Pharmaceuticals INC. | $15.01 | 2024 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Omori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.